Unique Ingredient Identifier 023C2WHX2V is listed as a ingredient substance
| RN | 77-86-1 |
| EC | 201-064-4 |
| NCIT | C47775 |
| RXCUI | 10865 |
| PUBCHEM | 6503 |
| INN ID | 1108 |
| MF | C4H11NO3 |
| INCHI KEY | LENZDBCJOHFCAS-UHFFFAOYSA-N |
| SMILES | NC(CO)(CO)CO |
UNII 023C2WHX2V TROMETHAMINE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTABLE | 1.1 % |
| IM - IV | INJECTION, SOLUTION | 1.21 % |
| INTRA-ARTERIAL | INJECTION | 0.24 % |
| INTRAMUSCULAR | INJECTION | 0.1 %W/V |
| INTRATHECAL | INJECTION | NA |
| INTRATHECAL | SOLUTION | 1.21 MG/ML |
| INTRATRACHEAL | SUSPENSION | 0.24 % |
| INTRATYMPANIC | SUSPENSION | 0.56 %W/W |
| INTRAVASCULAR | INJECTION | 1 % |
| INTRAVASCULAR | SOLUTION | 1.21 MG/ML |
| INTRAVASCULAR | SOLUTION, INJECTION | 0.1 % |
| INTRAVENOUS | INJECTABLE | 1.2 % |
| INTRAVENOUS | INJECTION | 1.2 % |
| INTRAVENOUS | SOLUTION | NA |
| INTRAVENOUS | SOLUTION, INJECTION | 0.12 %W/V |
| IV(INFUSION) | INJECTION | 0.005 % |
| IV(INFUSION) | POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED | 0.61 % |
| IV(INFUSION) | SOLUTION | 1.21 MG/ML |
| IV(INFUSION) | SOLUTION, INJECTION | 0.004 % |
| OPHTHALMIC | SOLUTION | 0.94 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.75 % |
| OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 0.8 % |
| OPHTHALMIC | SUSPENSION, DROPS | ADJPH |
| ORAL | CAPSULE, SOFT GELATIN | 15 MG |
| ORAL | SOLUTION | 1.21 MG/ML |
| ORAL | SOLUTION/DROPS | 0.76 %W/V |
| ORAL | TABLET | 14.01 MG |
| RECTAL | SOLUTION | 1.21 MG/ML |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 0.012 % |
| SUBCUTANEOUS | INJECTION | 0.6 % |
| TOPICAL | GEL | 0.8 %W/W |
| TOPICAL | SOLUTION | 8.4 %W/W |
| TRANSDERMAL | GEL | 0.1 %W/W |
| URETHRAL | SOLUTION | 0.12 % |